WaveBreak Therapeutics
PrivateLast Round
VC Round
Jan 25, 2021
Total Funding Raised
$23M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
WaveBreak Therapeutics is a biotechnology company that develops a platform of therapeutics to target protein-misfolding diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
WaveBreak Therapeutics Comparables
Compare WaveBreak Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Treventis Corporation | 87% | |
| Gismo Therapeutics | 84% | |
| MODAG | 81% |
WaveBreak Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 25, 2021 | ||||
| Series A | Jan 22, 2019 |
Key People
Founding team and executive leadership
WaveBreak Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lifeforce Capital | Series A, VC Round |
| Schooner Capital | VC Round |
| Industry Ventures | VC Round |
| The Baupost Group | Series A, VC Round |
| Malin PLC | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 321% MoM, reaching 2K.
- Jun 18, 2026
Monthly visitors increased 160% MoM.
WaveBreak Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about WaveBreak Therapeutics's valuation, stock price, and market status.
Is WaveBreak Therapeutics a public or private company?
WaveBreak Therapeutics is a private company.
What is the current stock price of WaveBreak Therapeutics?
WaveBreak Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is WaveBreak Therapeutics worth (valuation)?
Valuation information for WaveBreak Therapeutics is not publicly available.
Can I buy WaveBreak Therapeutics stock?
WaveBreak Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was WaveBreak Therapeutics's last funding round?
WaveBreak Therapeutics's most recent funding round was VC Round on January 25, 2021.
Who are the main investors in WaveBreak Therapeutics?
Key investors in WaveBreak Therapeutics include The Baupost Group.
Will WaveBreak Therapeutics IPO soon?
No public IPO plans have been announced for WaveBreak Therapeutics.
How can I track WaveBreak Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor WaveBreak Therapeutics's secondary market activity and sign up for updates.